title: Accumulation of natural and synthetic betaines by a mammalian renal cell line.
abstract: Intracellular accumulation of different betaines was compared in osmotically stressed Madin Darby canine kidney (MDCK) cells to model the betaine accumulation specificity of the mammalian inner medulla and to show how this accumulation differed from that of bacteria. All betaines accumulated less than glycine betaine. Arsenobetaine (the arsenic analogue of glycine betaine) accumulated to 12% of the glycine betaine levels and the sulphur analogue dimethylthetin accumulated to >80%. Most substituted glycine betaine analogues accumulated to 2-5% of intracellular glycine betaine concentrations, however, serine betaine accumulated to <0.5% of glycine betaine levels. Inhibition studies to distinguish the betaine ports were performed by the addition of proline. Butyrobetaine and carnitine accumulation was not proline sensitive, whereas that of other betaines was. As with glycine betaine, the accumulation of propionobetaine and dimethylthetin was proline sensitive and osmoregulated. Pyridinium betaine was accumulated by both proline-sensitive and -insensitive systems, with a small increase under osmotic stress. High concentrations (10 times that of glycine betaine) of the dietary betaines proline betaine and trigonelline inhibited total betaine accumulation. Because alpha-substituted betaines are accumulated by bacteria and not by MDCK cells, these betaines may be the basis for design of antimicrobial agents.
authors.affiliation: Department of Clinical Biochemistry, Christchurch Hospital, New Zealand.
authors.forename: K
authors.initials: K
authors.lastname: Randall
authors.forename: M
authors.initials: M
authors.lastname: Lever
authors.forename: B A
authors.initials: BA
authors.lastname: Peddie
authors.forename: S T
authors.initials: ST
authors.lastname: Chambers
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000737:chemistry; D001419:Bacteria / Q000378:metabolism; D001622:Betaine / Q000031:analogs & derivatives / Q000138:chemical synthesis / Q000737:chemistry / Q000378:metabolism*; D002331:Carnitine / Q000378:metabolism; D002352:Carrier Proteins / Q000378:metabolism; D002412:Cations / Q000737:chemistry; D002460:Cell Line; D004285:Dogs; D015195:Drug Design; D004848:Epithelium / Q000378:metabolism; D050485:GABA Plasma Membrane Transport Proteins; D006982:Hypertonic Solutions / Q000494:pharmacology; D007424:Intracellular Fluid / Q000378:metabolism; D007679:Kidney Medulla / Q000378:metabolism*; D015394:Molecular Structure; D009997:Osmotic Pressure; D011392:Proline / Q000494:pharmacology; D013045:Species Specificity
chemical_list: D000900:Anti-Bacterial Agents; D002352:Carrier Proteins; D002412:Cations; D050485:GABA Plasma Membrane Transport Proteins; D006982:Hypertonic Solutions; C072207:betaine plasma membrane transport proteins; D001622:Betaine; D011392:Proline; D002331:Carnitine